// App-Quantinova.ai

POS1175 (2021) : ASSESSMENT OF THE COVID-19 PANDEMIC FROM THE PERSPECTIVE OF PEOPLE WITH RHEUMATIC MUSCULOSKELETAL DISEASES IN EUROPE. RESULTS FROM THE REUMAVID STUDY (PHASE 1)

Researchers

Presenter

  • M. Garrido-Cumbrera

Principal Investigators

  • H. Marzo-Ortega

  • J. Correa-Fernndez

  • S. Sanz-Gomez

  • L. Christen

  • V. Navarro-Compn

Medical Centers

  • Universidad de Sevilla, Health & Territory Research (HTR), Seville, Spain

  • University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

  • Novartis Pharma AG, Patient Engagement, Basel, Spain

  • Hospital Universitario La Paz, Madrid, Spain

Locations

  • Spain

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cross-Sectional

Phase

  • I

Study Id's

  • N/A

Sponsors

  • Janssen and Novartis

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved